Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

AZ and Lilly set up BACE camp for Alzheimer’s

Lilly will pay AZ up to $500m in development and regulatory costs

- PMLiVE

Beard growing challenge to raise money for prostate cancer

OctoBeardFest follows huge success of Movember

- PMLiVE

Rosetta appoints creative director in healthcare

Scott Reese was most recently CEO of Wool Labs

- PMLiVE

Pharma is turning its attention to consumer healthcare

Pharma is no stranger to over-the-counter remedies but, as a number of recent deals show, consumer healthcare’s star is rising

- PMLiVE

Sovaldi deal for developing world ‘falls short’

Critics claim Gilead have allowed Indian companies to set their own price

- PMLiVE

Brain tumour vaccine is UK’s first ‘Promising Innovative Medicine’

Northwest Biotherapeutics’ DCVax-L gets UK version of ‘breakthrough’ status for use in cancer

- PMLiVE

Lundbeck launches Brintellix in first EU market

The antidepressant set to sell worldwide

Roche - Basel

Roche moves eye drug lampalizumab into phase III

It could be the first treatment for geographic atrophy

Array appoints Victor Sandor chief medical officer

He joins from Incyte and will replace Michael Needle

- PMLiVE

NHS ‘not driving’ health innovation

Minister for Life Sciences acknowledges UK has more to do

- PMLiVE

Seven steps to innovating your digital strategy

Dealing with digitally native HCPs

- PMLiVE

UK pharmacists to have greater role in public health

Community pharmacies should be part of ‘primary care family’, says Kevin Fenton

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links